Researchers have made a “promising” breakthrough in the race to develop a “holy grail” vaccine that can offer protection against multiple Covid variants and a variety of common colds caused by other coronaviruses.
Efforts to design a so-called “pan-coronavirus vaccine” have so far proved largely fruitless. This type of jab would need to remain effective in the face of frequent mutations.
